Deutscher Studienpreis award ceremony for Felix Lansing in Berlin
For this groundbreaking contribution to finding treatment for more then 8,000 diseases that can be traced back to gene defect, Felix Lansing was awarded second place in the Deutscher Studienpreis of the Körber Foundation. The award ceremony took place in … Continue reading
Posted in Uncategorized
Comments Off
Felix Lansing awarded German Study Prize in Natural and Technical Sciences
Dr Felix Lansing has made a groundbreaking contribution to cell and gene therapy, for which he was awarded 2nd place in the Deutscher Studienpreis by the Körber Foundation. “In my dissertation,” outlines Dr Lansing, “I developed a new molecular scalpel … Continue reading
Posted in Uncategorized
Comments Off
New start-up company RecTech GmbH founded
RecTech GmbH is a brand new start-up focused on developing designer recombinases for precision genome editing. Supported by the BMBF GO-Bio programme, the lab of Frank Buchholz founded the company to translate its scientific findings into a translational pipeline. @RecTech_Dresden … Continue reading
Posted in Uncategorized
Comments Off
Designer recombinase can precisely correct disease-relevant gene defect in severe form of hemophilia A
The research team led by Prof. Frank Buchholz at the Carl Gustav Carus Medical Faculty of the Technical University of Dresden has succeeded in developing an enzyme that can efficiently and specifically correct a gene mutation in the Factor VIII … Continue reading
Posted in Uncategorized
Comments Off
Interview on communication in science with Prof. Dr. Frank Buchholz
mdr Sachsen podcast broadcasts interview with Prof. Dr. Frank Buchholz on communication in science On 18 January 2022, mdr Sachsen published a podcast on the topic “Is there a therapy for Long Covid?” in which Prof. Dr. Frank Buchholz comments … Continue reading
Posted in Uncategorized
Comments Off